(RTTNews) - Polyrizon Ltd. (PLRZ), a biotechnology company developing intranasal products, reported encouraging preclinical findings showing that its proprietary Trap and Target naloxone hydrogel ...
Ra’anana, Israel, Dec. 03, 2025 (GLOBE NEWSWIRE) -- Polyrizon Ltd. (Nasdaq: PLRZ) (“Polyrizon” or the “Company”), a biotechnology company focusing on the development of intranasal products, today ...
Polyrizon Ltd. (NASDAQ: PLRZ) stock traded sharply higher Thursday as volume spiked to 18.56 million shares, well above the typical 2.62 million average, Benzinga Pro data showed. Polyrizon on ...
RA’ANANA, Israel - Polyrizon Ltd. (NASDAQ:PLRZ) announced Wednesday that its experimental naloxone hydrogel demonstrated superior mucoadhesion compared to a marketed intranasal naloxone spray in ...
Looking to improve drug product effectiveness and differentiate? Mucoadhesion – the ability of a formulation to adhere to a mucous membrane – is an attractive option for those keen to ensure their ...
Superior Mucoadhesion may potentially Translate into More Reliable Opioid Overdose Reversal in Real-World Emergencies Ra'anana, Israel, Dec. 03, 2025 (GLOBE NEWSWIRE) -- Polyrizon Ltd. (Nasdaq: PLRZ) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results